9-32986032-T-TAAAAAAAAACAAA
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001195248.2(APTX):c.484-3_484-2insTTTGTTTTTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00085 ( 7 hom. )
Consequence
APTX
NM_001195248.2 splice_region, intron
NM_001195248.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.384
Genes affected
APTX (HGNC:15984): (aprataxin) This gene encodes a member of the histidine triad (HIT) superfamily. The encoded protein may play a role in single-stranded DNA repair through its nucleotide-binding activity and its diadenosine polyphosphate hydrolase activity. Mutations in this gene have been associated with ataxia-ocular apraxia. Alternatively spliced transcript variants have been identified for this gene.[provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 9-32986032-T-TAAAAAAAAACAAA is Benign according to our data. Variant chr9-32986032-T-TAAAAAAAAACAAA is described in ClinVar as [Likely_benign]. Clinvar id is 2112401.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000855 (614/718470) while in subpopulation EAS AF= 0.00364 (89/24424). AF 95% confidence interval is 0.00303. There are 7 homozygotes in gnomad4_exome. There are 330 alleles in male gnomad4_exome subpopulation. Median coverage is 10. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000139 AC: 2AN: 14392Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
2
AN:
14392
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000855 AC: 614AN: 718470Hom.: 7 Cov.: 10 AF XY: 0.000889 AC XY: 330AN XY: 371398
GnomAD4 exome
AF:
AC:
614
AN:
718470
Hom.:
Cov.:
10
AF XY:
AC XY:
330
AN XY:
371398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000139 AC: 2AN: 14388Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 6662
GnomAD4 genome
AF:
AC:
2
AN:
14388
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
6662
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at